NVCR Stock Analysis: Buy, Sell, or Hold?
NVCR - NovoCure Limited Ordinary Shares
$15.59
-0.12 (-0.76%)
âŧ
5d:
+12.64%
30d:
-6.48%
90d:
-22.01%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 29, 2026
6d
Get Alerted When NVCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: NVCR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: NVCR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: NVCR is currently trading at $15.59, which is considered fair relative to its 30-day fair value range of $14.61 to $16.34.
Technical Outlook: Technically, NVCR is in a strong downtrend. Immediate support is located at $13.76, while resistance sits at $16.09.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.86 (+72.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NVCR is in a strong downtrend. Immediate support is located at $13.76, while resistance sits at $16.09.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.86 (+72.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$14.61 -
$16.34
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Protect Your Profits
Holding NVCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 72.3% below Wall St target ($26.86)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$14.61 -
$16.34
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$13.76
Resistance Level
$16.09
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.33
Wall Street Target
$26.86
(+72.3%)
Revenue Growth (YoY)
15.6%
Earnings Growth (YoY)
-6.0%
Profit Margin
-21.2%
Share & Embed Analysis
Last updated: October 21, 2026 7:09 PM ET
Data refreshes hourly during market hours. Next update: 8:09 PM
Data refreshes hourly during market hours. Next update: 8:09 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 53 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
CATX
Perspective TherapeuticsâĻ |
STRONG BUY
14 analysts |
$12 | 60 HOLD |
Advanced NVCR Option Strategies
Professional options setups generated by AI based on today's NVCR price and gamma walls.
